Multicenter phase 1/2a study using T-cell receptor gene therapy in metastatic melanoma
Read time: 1 mins
Last updated:2nd Apr 2012
To study the efficacy of this treatment strategy in inducing tumor-specific T cell immunity as measured by the presence of Mart-1 specific T cells in peripheral blood samples on several time points following adoptive transfer.
|Study start date||2012-04-02|